EXEL Related Analyst Ratings
-
Merriman Curhan Ford Downgrades Exelixis (EXEL) to Neutral; Valuation Call
-
Boenning & Scattergood Initiates Coverage on Exelixis (EXEL) with a Neutral
-
Canaccord Adams Initiates Coverage on Several Life Sciences Stocks: ALTH, EXEL, MITI, NPSP, OSIP, ONXX, PARD, SGEN & SNTA
-
Piper Jaffray Downgrades Exelixis (EXEL) to Neutral
-
Susquehanna Initiates Coverage on Exelixis (EXEL) with a Positive
-
Canaccord Downgrades Exelixis (EXEL) to Hold
-
Lazard Capital Starts Exelixis (EXEL) at Buy
-
Wachovia downgrades Exelixis (EXEL) to Market Perform
-
WR Hambrecht Starts Exelixis (EXEL) at Buy
-
Piper Jaffray Said BAY/ONXX Approval for Nexavar is a Positive for EXEL
-
Banc of America Initiates Coverage on a Number of Biotech Stocks
-
JMP Securities Upgraded EXEL
Back to EXEL Stock Lookup
